New Drug To Treat a Desperate Disease


Idiopathic pulmonary fibrosis (IPF)

New Drug To Treat a Desperate Disease

Author
- Dr. Gifford Jones  Sunday, January 20, 2013
| Print friendly | Email Us

Several months ago I wrote about a tennis partner who was slowly dying of idiopathic pulmonary fibrosis (IPF). We both knew there was no cure for this disease. Nor could I foresee any help for many years. I was wrong on that point. But I was right about my message of hope.

I always tell seriously ill patients the story of the man sentenced to death by the King. Because the King was a lover of horses, the man received a reprieve by promising he’d teach the King’s horse to fly within one year. His friends laughed at him, but he explained, “Within a year the King may die, I may die or the horse may die. Besides, within a year the horse may learn to fly.” The last thing to lose is hope.

Patients with IPF face a grim future. The average length of life from the time of diagnosis of IPF is usually two to five years. Fortunately, fate is occasionally kind, as some patients have lived as long as 20 years.

In some cases the course of the disease remains fairly stable. This was the case of my tennis friend. But then it became apparent that the disease was beginning to progress. During tennis games he developed a dry hacking cough, chest discomfort, but even more ominous, progressive shortness of breath along with weakness and fatigue.

IPF is associated with extensive, progressive, scarring of lung tissue. The alveoli (air sacs) in lungs begin to stiffen and become thick, decreasing the amount of oxygen in the blood stream. In effect, IPF is a slow strangulation of the body’s vital oxygen supply.

During final days any physical activity becomes an extreme effort. As my friend remarked, “It requires hours to do anything. It’s like being trapped under water and trying to surface for air.” It’s easy to understand how doctors treating these cases feel frustrated as there’s little to offer in treatment.

Sir William Olser, one of this country’s greatest physicians, felt this way when a colleague asked how he treated another difficult problem, emphysema. Osler replied, “I send these patients to Egypt”. His startled colleague asked,”Is it for the climate?” “No” Osler replied, “It’s the farthest place I can think of to send them.” It was Osler’s way of saying he had no treatment to offer them.

I had no idea when I wrote about IPF several months ago that in this short interval I’d have good news for some IPF patients. A new medication called. “Esbriet” (pirfenidone) is now available in Germany, France, Sweden, Austria, Denmark, Norway, Iceland, 27 countries in the European Union, and has just been approved by Health Canada.

Dr. Charles Chan, Professor of Medicine and Respirologist at the University of Toronto, once shared Osler’s frustration. But now he’s says “After a decade of failed clinical trials of multiple innovative drugs for IPF, Esbriet is an exciting one for IPF patients. Finally we have a treatment option with proven benefit for patients with this challenging disease.”

Esbriet is designed to fight a two-pronged attack on the underlying problems of idiopathic pulmonary fibrosis, namely the inflammation and tough scarring that eventually choke and kill lung tissue.

Esbriet accomplishes this task by decreasing the formation of cells called fibroblasts that are responsible for triggering scarring and fibrosis of air sacs in the lungs. In addition, Esbriet has an anti-inflammatory effect which helps to slow down the progression of the disease and thereby preserves exercise tolerance.

The usual dose is one oral tablet three times a day. Fortunately, Esbriet is well tolerated by most patients. A few complain of nausea, fatigue, diarrhea and heartburn.

Even if Esbriet had been available several months ago it would not have helped my friend as his IPF was too advanced at that time. But Esbriet can help to decrease the progression of those who suffer from the mild to moderate form of IPF. This is a huge step in the right direction to fight this challenging disease. And Osler would be pleased to know Egypt need no longer be an option.

Disqus Comments

W. Gifford-Jones M.D is the pen name of Dr. Ken Walker graduate of Harvard. Dr. Walker’s website is: docgiff.com.

Dr. Walker can be reached at: .(JavaScript must be enabled to view this email address).

.






Most Shared CFP stories



What's New On CFP:

  1. The Useless Jewish Organization
    By Daniel Greenfield -- --American Politics
  2. Obama: You know…I could run a third term were it not for that pesky constitution!
    By Dag Barkley -- --Cartoons
  3. EPA deletes “navigable” from statute – states sue
    By Ron Arnold -- --Global Warming-Energy-Environment
  4. Equality Obama-style: profiteering of neighborhoods, fetal organs
    By A. Dru Kristenev -- --Cover Story
  5. Clinton admires racial purist Margaret Sanger
    By David L. Hunter -- --Cover Story
  6. Obama’s Kenya Flights Cost $6 million, Now Tied for Most Total International Trips
    By News on the Net -- --American Politics
  7. Gay marriage endorsement mars Obama’s Africa tour
    By News on the Net -- --News Headlines
  8. 3rd Shock Video Catches Planned Parenthood Vice President Selling Body Parts of Aborted Babies
    By News on the Net -- --News Headlines
  9. Global warming update: There’s still snow on the ground in Buffalo
    By Dan Calabrese -- --Global Warming-Energy-Environment
  10. Why are Tattoos Permanent? (video)
    By American Chemical Society -- --Video
  11. Drivers, Beware: The Costly, Deadly Dangers of Traffic Stops in the American Police State
    By John W. Whitehead -- --American Freedom
  12. Pesticides From Plants
    By Jack Dini -- --Global Warming-Energy-Environment
  13. Obama says that, if he ran, he would win a third term - but he’s ‘not above the law’
    By Robert Laurie -- --American Politics
  14. White House denial of IRS abuse is getting pretty pathetic
    By Herman Cain -- --American Politics
  15. Florida: Model’s fashion shoot interrupted by boatload of illegals scrambling ashore
    By Robert Laurie -- --Crime-Terror-Security
  16. La Tranchardière – a slice of France
    By Tim Saunders -- --Vacation Resorts, Travel
  17. Don’t worry about ‘Climate Security’, Global warming gang’s got you covered
    By Judi McLeod -- --Cover Story
  18. The Islamic State, the Caucasus, and the Russian Response
    By INSS -- --World News
  19. Horror: Third Planned Parenthood Video Captures Abortionists Procuring Fetal Tissue for Profit(Video
    By News on the Net -- --News Headlines
  20. AIM Editor on FAA’s Air Traffic Control Hiring Scandal [Video]
    By Roger Aronoff -- --Media - Media Bias
  21. What Killed the Mammoths—Heatstroke or Frostbite?
    By Dr. Klaus L.E. Kaiser -- --Global Warming-Energy-Environment
  22. Supreme Court unfair to Harper government, new Ontario justice wrote as professor
    By News on the Net -- --News Headlines
  23. What the Hell? Chuck Todd says my favorability rating is dismal?
    By Dag Barkley -- --Cartoons
  24. Cincinnati Incident Shows Law-Abiding Citizens Can Fight Back, Says CCRKBA
    By CCRKBA -- --Gun Control - Second Amendment
  25. Camp Lone Star – The World Turned Upside Down
    By Gary Hunt -- --American Freedom
  26. Is a Criminal Probe of Clinton Near?
    By Matthew Vadum -- --Cover Story
  27. Obama to Africa: Get over your past, stop relying on others and solve your own problems
    By Dan Calabrese -- --Cover Story
  28. For Kate and America’s Sake, Don’t Let Them Get Away with It
    By Lloyd Marcus -- --Cover Story
  29. People living in countries with high levels of economic freedom are happier and have greater life s
    By Fraser Institute -- --Financial, Business, Economy
  30. GOP Leadership Prioritizes Corporate Welfare Over Defunding Planned Parenthood
    By Heritage Foundation -- --News Headlines










Caruba: Professional Writing Services